title: Biomarkers for pancreatic cancer: is it ready for primetime?
authors.forename: Richard
authors.initials: R
authors.lastname: Kim
authors.forename: Amit
authors.initials: A
authors.lastname: Mahipal
authors.forename: Minsig
authors.initials: M
authors.lastname: Choi
authors.forename: Mohammad Wasif
authors.initials: MW
authors.lastname: Saif
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D042943:Dihydrouracil Dehydrogenase (NADP) / Q000378:metabolism; D033721:Equilibrative Nucleoside Transporter 1 / Q000378:metabolism; D006801:Humans; D015676:Osteonectin / Q000378:metabolism; D017063:Outcome Assessment, Health Care; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; D033721:Equilibrative Nucleoside Transporter 1; D015676:Osteonectin; C438649:SLC29A1 protein, human; C577241:SPARC protein, human; D042943:Dihydrouracil Dehydrogenase (NADP)